Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Bicara Therapeutics Inc. (NASDAQ: BCAX) closed at $19.00 down -6.40% from its previous closing price of $20.30. In other words, the price has decreased by -$6.40 from its previous closing price. On the day, 0.84 million shares were traded. BCAX stock price reached its highest trading level at $20.662 during the session, while it also had its lowest trading level at $18.58.
Ratios:
For a deeper understanding of Bicara Therapeutics Inc.’s stock, let’s take a closer look at its various ratios.
On October 08, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $47.
On October 08, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $35.Morgan Stanley initiated its Overweight rating on October 08, 2024, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 1,833,000 shares for $18.00 per share. The transaction valued at 32,994,000 led to the insider holds 4,303,418 shares of the business.
Flynn James E bought 70,000 shares of BCAX for $1,260,000 on Sep 17 ’24. The Possible Members of 10% Group now owns 897,587 shares after completing the transaction at $18.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAX now has a Market Capitalization of 1104616320 and an Enterprise Value of 183386720.
Stock Price History:
Over the past 52 weeks, BCAX has reached a high of $27.94, while it has fallen to a 52-week low of $20.11. The 50-Day Moving Average of the stock is -22.28%, while the 200-Day Moving Average is calculated to be -22.28%.
Shares Statistics:
For the past three months, BCAX has traded an average of 621.15K shares per day and 377390 over the past ten days. A total of 51.76M shares are outstanding, with a floating share count of 39.16M. Insiders hold about 24.35% of the company’s shares, while institutions hold 22.78% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
